Serum high density lipoprotein cholesterol level and risk of death: let's avoid the extremes

Hamid Moradi^{1

2}, Elani Streja^{1

2}, Kamyar Kalantar-Zadeh^{1

2}

Affiliations

¹ Division of Nephrology and Hypertension, University of California, Irvine, USA.
² Long Beach VA Healthcare System, Department of Medicine, Nephrology Section, Long Beach, USA.

Editorial

Hamid Moradi et al. J Thorac Dis. 2017 Dec.

. 2017 Dec;9(12):4849-4852.

doi: 10.21037/jtd.2017.10.155.

Hamid Moradi^{1

2}, Elani Streja^{1

2}, Kamyar Kalantar-Zadeh^{1

2}

¹ Division of Nephrology and Hypertension, University of California, Irvine, USA.
² Long Beach VA Healthcare System, Department of Medicine, Nephrology Section, Long Beach, USA.

No abstract available

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Extreme high high-density lipoprotein cholesterol is paradoxically associated with high mortality in men and women: two prospective cohort studies.
Madsen CM, Varbo A, Nordestgaard BG. Madsen CM, et al. Eur Heart J. 2017 Aug 21;38(32):2478-2486. doi: 10.1093/eurheartj/ehx163. Eur Heart J. 2017. PMID: 28419274

1. Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004;364:937-52. 10.1016/S0140-6736(04)17018-9 - DOI - PubMed
1. Gordon DJ, Rifkind BM. High-density lipoprotein--the clinical implications of recent studies. N Engl J Med 1989;321:1311-6. 10.1056/NEJM198911093211907 - DOI - PubMed
1. Schwartz GG, Olsson AG, Abt M, et al. Effects of dalcetrapib in patients with a recent acute coronary syndrome. N Engl J Med 2012;367:2089-99. 10.1056/NEJMoa1206797 - DOI - PubMed
1. AIM-HIGH Investigators , Boden WE, Probstfield JL, et al. Niacin in patients with low HDL cholesterol levels receiving in-tensive statin therapy. N Engl J Med 2011;365:2255-67. 10.1056/NEJMoa1107579 - DOI - PubMed
1. Barter PJ, Caulfield M, Eriksson M, et al. Effects of torcetrapib in patients at high risk for coronary events. N Engl J Med 2007;357:2109-22. 10.1056/NEJMoa0706628 - DOI - PubMed